June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Effect of IOP Reduction on Pattern ERG in Patients with Early Stage Glaucoma.
Author Affiliations & Notes
  • Andrea Tornero-Jimenez
    Instituto de Oftalmologia y Ciencias Visuales, Universidad de Guadalajara, Guadalajara, jalisco, Mexico
    Research Department, Unidad de Diagnóstico temprano del Glaucoma, Guadalajara, jalisco, Mexico
  • Jose A Paczka
    Instituto de Oftalmologia y Ciencias Visuales, Universidad de Guadalajara, Guadalajara, jalisco, Mexico
    Research Department, Unidad de Diagnóstico temprano del Glaucoma, Guadalajara, jalisco, Mexico
  • Luz A. Giorgi-Sandoval
    Research Department, Unidad de Diagnóstico temprano del Glaucoma, Guadalajara, jalisco, Mexico
    Research Department, Asistencia e Investigacion en Glaucoma, Guadalajara, jalisco, Mexico
  • Fabiola Guerrero-Cuevas
    Research Department, Unidad de Diagnóstico temprano del Glaucoma, Guadalajara, jalisco, Mexico
    Research Department, Asistencia e Investigacion en Glaucoma, Guadalajara, jalisco, Mexico
  • Footnotes
    Commercial Relationships   Andrea Tornero-Jimenez, None; Jose Paczka, None; Luz Giorgi-Sandoval, None; Fabiola Guerrero-Cuevas, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 3864. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Andrea Tornero-Jimenez, Jose A Paczka, Luz A. Giorgi-Sandoval, Fabiola Guerrero-Cuevas; Effect of IOP Reduction on Pattern ERG in Patients with Early Stage Glaucoma.. Invest. Ophthalmol. Vis. Sci. 2020;61(7):3864.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The pattern electroretinogram (pERG) closely depends on normal RGC activity, and therefore represents an objective and direct measure of RGC function. This functional test has been shown to be altered in ocular hypertension and glaucoma. The purpose of the study is to determine the effect of IOP reduction on pERG of a cohort of early stage glaucoma patients.

Methods : Twenty three consecutive untreated glaucoma patients (at an early stage of the disease based on a definition using clinical, perimetric and tomographic findings) were assesed by pERG (Diopsys-NOVA contrast sensitivity module; Pine Brook, NJ, E.U.A.), before and after undergoing pharmacological ocular hypotensive therapy. The effect of IOP reduction was compared with functional and structural changes, incuding three pERG variables (magnitude, magnitudeD and magnitudeD/magnitude ratio). Non-parametric statistical methods were used. A P value of less tan 0.05 was considered as statistically significant.

Results : Participants were predominantly female (69.5%), older than 50 years of age (median, 61 years), and affected by primary open-angle glaucoma (82.6%). No significant changes were observed comparing pre- and post-antiglaucoma treatment moments of perimetric indexes (medians: MD, - 3.72 dB vs. - 3.14 dB; PSD, 4.01 dB vs. 4.18 dB) from a mínimum of four visual fields per eye; as well as of tomographic parameters (medians: average CFNR, 90 µm vs. 92 µm; rim area, 1.15 mm2 vs. 1.11 mm2); in contrast, statistically significant differences were observed at the two different moments regarding IOP (medians, 22 mm Hg vs. 16 mm Hg; P = 0.001), as well is in pERG variables (medians: magnitude, 1.39 µv vs. 2.34 µv, P = 0.014; magnitudeD, 1.01 µv vs. 2.18 µv, P = 0.028; magnitudeD/magnitude ratio, 0.70 µv vs. 0.98 µv, P = 0.049).

Conclusions : A clinically significant IOP reduction in previously untreated patients with early glaucoma seems to improve electrical activity of ganglion cells measured by pERG which could be used as a sensitive biomarker of therapeutic efficacy in glaucoma patients during its earliest stages.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×